Target intelligence / Profile preview

Eukaryotic 60S ribosomal subunit 28S rRNA sarcin–ricin loop (SRL)

Target
SRL
Molecular classification
Ribosomal RNA, Non-coding RNA, Ribonucleic acid, Ribosome component
01

Overview

The eukaryotic 60S ribosomal subunit 28S rRNA sarcin–ricin loop (SRL) is a highly conserved, 12-nucleotide RNA structure located within the large ribosomal subunit that is essential for protein synthesis (Grela et al., 2019, Molecules). It functions as a critical docking site for translation elongation factors (eEF-1 and eEF-2) and is necessary for the activation of their GTPase activity, which drives the translocation step of translation (Endo & Wool, 1982, JBC). The SRL is the specific molecular target for Ribosome-Inactivating Proteins (RIPs) such as ricin, which acts as an N-glycosidase to remove a specific adenine residue (A4324 in humans), and alpha-sarcin, which cleaves the phosphodiester bond between G4325 and A4326 (Stirpe & Battelli, 2006, CMLS). These covalent modifications prevent elongation factors from binding, effectively halting protein synthesis and triggering apoptosis. In a clinical context, the SRL is targeted by experimental immunotoxins, where RIPs are conjugated to monoclonal antibodies to treat various cancers by inducing selective cell death (Walsh et al., 2013, Toxins).

Other names
Sarcin-ricin loopSRL28S rRNA sarcin-ricin domainAlpha-sarcin loopA4324 loop
02

Mechanism of action

Ribosome-inactivating proteins (RIPs) target the SRL through either N-glycosidase activity, which depurinates a specific adenine (e.g., ricin, Shiga toxin), or ribonuclease activity, which cleaves a specific phosphodiester bond (e.g., alpha-sarcin). These modifications disrupt the binding and GTPase activation of elongation factors eEF-1 and eEF-2, leading to the irreversible inhibition of protein synthesis (Grela et al., 2019, Molecules; Endo & Wool, 1982, JBC).

03

Biological functions

Translation elongationGTPase activationElongation factor bindingProtein synthesis
04

Disease associations

Toxin-mediated cell deathCancerInfection
05

Safety considerations

Extreme systemic toxicityVascular leak syndromeImmunogenicityOff-target cytotoxicity
06

Interacting drugs

Ricin

5 more in the full profile.

07

Biomarkers

Depurinated 28S rRNAInhibition of protein synthesisCleaved 28S rRNA fragmentsp38 MAPK phosphorylation

Beyond the preview

Go deeper on Eukaryotic 60S ribosomal subunit 28S rRNA sarcin–ricin loop (SRL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic 60S ribosomal subunit 28S rRNA sarcin–ricin loop (SRL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call